Is urinary NGAL determination useful for monitoring kidney function and assessment of cardiovascular disease? : a 12-month observation of patients with type 2 diabetes

2016
journal article
article
19
cris.lastimport.scopus2024-04-24T06:20:13Z
dc.abstract.enBackground. Diabetic kidney disease (DKD) may start as glomerular or tubular damage. We assessed kidney function during oneyear-long observation of patients with type 2 diabetes mellitus (T2DM) after initiation of nephroprotective treatment, with emphasis on the changes in urinary neutrophil gelatinase-associated lipocalin (uNGAL), and evaluated the association between tubular damage and cardiovascular complications of T2DM. Materials and Methods. Adult T2DM patients (55) were assessed initially and 30 patients after 1 year. Albumin and uNGAL and creatinine were measured in first morning urine. Albumin/creatinine (uACR) and uNGAL/creatinine (uNCR) ratios were calculated. Results. In logistic regression, both uACR above 30 mg/g and uNCR the median (21.3 𝜇g/g) were associated with cardiovascular complications, independently of classical risk factors and diabetes duration. One year after initiation of treatment, a significant reduction in HbA1c was observed. BMI and lipid profiles did not change. Increase in serum creatinine and reduction in eGFR occurred, along with decrease in uNGAL and uNCR. Increasing uNCR and uACR were associated with higher control HbA1c. The increase in uNCR was more frequent in patients with hypertension. Conclusions. Better glycemic control in T2DM patients results in improved tubular function, as reflected by reduced uNCR and uNGAL. First morning urine uNGAL and uNCR may be useful to assess renal function and cardiovascular risk, along with albuminuria and eGFRpl
dc.affiliationWydział Farmaceutyczny : Zakład Diagnostyki Medycznejpl
dc.affiliationWydział Lekarski : Zakład Fizjologii Klinicznejpl
dc.affiliationWydział Lekarski : Klinika Nefrologiipl
dc.affiliationWydział Lekarski : Zakład Patofizjologiipl
dc.affiliationWydział Lekarski : Zakład Farmakologiipl
dc.affiliationWydział Lekarski : Zakład Diagnostykipl
dc.cm.date2020-01-07
dc.cm.id79645
dc.contributor.authorŻyłka, Agnieszkapl
dc.contributor.authorGala-Błądzińska, Agnieszkapl
dc.contributor.authorDumnicka, Paulina - 186623 pl
dc.contributor.authorCeranowicz, Piotr - 128981 pl
dc.contributor.authorKuźniewski, Marek - 130575 pl
dc.contributor.authorGil, Krzysztof - 129499 pl
dc.contributor.authorOlszanecki, Rafał - 133033 pl
dc.contributor.authorKuśnierz-Cabala, Beata - 130567 pl
dc.date.accessioned2020-01-17T09:10:36Z
dc.date.available2020-01-17T09:10:36Z
dc.date.issued2016pl
dc.date.openaccess0
dc.description.accesstimew momencie opublikowania
dc.description.points25pl
dc.description.versionostateczna wersja wydawcy
dc.description.volume2016pl
dc.identifier.articleid8489543pl
dc.identifier.doi10.1155/2016/8489543pl
dc.identifier.eissn1875-8630pl
dc.identifier.issn0278-0240pl
dc.identifier.projectROD UJ / OPpl
dc.identifier.urihttps://ruj.uj.edu.pl/xmlui/handle/item/138999
dc.languageengpl
dc.language.containerengpl
dc.rightsUdzielam licencji. Uznanie autorstwa 4.0 Międzynarodowa*
dc.rights.licenceCC-BY
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/legalcode.pl*
dc.share.typeotwarte czasopismo
dc.subtypeArticlepl
dc.titleIs urinary NGAL determination useful for monitoring kidney function and assessment of cardiovascular disease? : a 12-month observation of patients with type 2 diabetespl
dc.title.journalDisease Markerspl
dc.typeJournalArticlepl
dspace.entity.typePublication

* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.

Views
0
Views per month